Real world retrospective cohort study comparing effectiveness and economic benefit of Cell-Based Quadrivalent Seasonal Influenza Vaccine (QIVc) with an egg-based quadrivalent influenza vaccine (QIVe)
Latest Information Update: 16 May 2021
Price :
$35 *
At a glance
- Drugs Influenza vaccine (Optaflu) (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Therapeutic Use
- 16 May 2021 New trial record
- 25 Mar 2021 According to a Seqirus media release, results were published in in peer-reviewed medical journal Vaccines.
- 25 Mar 2021 Results published in the Seqirus Media Release.